Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,830.50p on 02-11-2026 at 16:25:15
Change -24.50p -1.32%
Buy 1,831.00p
Sell 1,830.50p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 200.00 at 1,830.50p
Day's Volume: 2,019,862
Last Close: 1,855.00p
Open: 1,831.50p
ISIN: GB00BN7SWP63
Day's Range 1,824.50p - 1,845.50p
52wk Range: 1,735.50p - 2,282.00p
Market Capitalisation: £73.35b
VWAP: 1,833.34128p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 200 1,830.50p Automatic Execution
 16:25:05 - 02-Nov-26
Sell* 38 1,830.50p Automatic Execution
 16:24:47 - 02-Nov-26
Sell* 775 1,830.50p Automatic Execution
 16:24:47 - 02-Nov-26
Unknown* 0 1,831.00p SI Trade
 16:24:42 - 02-Nov-26
Buy* 1 1,831.00p SI Trade
 16:24:35 - 02-Nov-26
Buy* 17 1,831.00p Automatic Execution
 16:24:26 - 02-Nov-26
Buy* 650 1,831.00p Automatic Execution
 16:24:19 - 02-Nov-26
Buy* 13 1,831.00p Automatic Execution
 16:24:19 - 02-Nov-26
Sell* 10 1,830.50p Automatic Execution
 16:24:09 - 02-Nov-26
Sell* 35 1,830.50p Automatic Execution
 16:24:09 - 02-Nov-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Nov 2026 (Mon) 1,831.50 1,845.50 1,824.50 1,855.00 2,019,862
30th Oct 2026 (Fri) 1,838.00 1,877.00 1,830.50 1,855.00 13,549,796
29th Oct 2026 (Thu) 1,790.00 1,842.50 1,790.00 1,814.00 9,351,620
28th Oct 2026 (Wed) 1,879.50 1,879.50 1,783.50 1,831.50 16,829,097
27th Oct 2026 (Tue) 1,907.00 1,925.50 1,902.50 1,923.50 3,982,525
26th Oct 2026 (Mon) 1,903.00 1,921.50 1,898.00 1,915.00 3,085,590
23rd Oct 2026 (Fri) 1,911.50 1,911.50 1,881.00 1,894.00 5,516,426
22nd Oct 2026 (Thu) 1,875.00 1,917.00 1,863.00 1,914.00 4,466,031
21st Oct 2026 (Wed) 1,863.50 1,884.00 1,856.50 1,868.00 11,052,161
20th Oct 2026 (Tue) 1,870.00 1,879.50 1,855.00 1,868.50 5,286,220
19th Oct 2026 (Mon) 1,871.00 1,871.00 1,851.00 1,855.00 4,924,273
16th Oct 2026 (Fri) 1,843.00 1,870.00 1,842.50 1,862.50 12,806,361
15th Oct 2026 (Thu) 1,823.50 1,876.50 1,812.00 1,868.50 12,523,051
14th Oct 2026 (Wed) 1,740.00 1,816.00 1,740.00 1,816.00 7,626,757
13th Oct 2026 (Tue) 1,797.00 1,806.50 1,753.00 1,753.00 6,612,895
12th Oct 2026 (Mon) 1,755.00 1,771.00 1,751.00 1,771.00 3,351,693
9th Oct 2026 (Fri) 1,752.00 1,771.50 1,748.50 1,750.00 6,930,730
8th Oct 2026 (Thu) 1,773.00 1,773.00 1,735.50 1,735.50 16,330,339
7th Oct 2026 (Wed) 1,754.50 1,791.00 1,747.00 1,790.50 5,172,175
6th Oct 2026 (Tue) 1,769.50 1,786.50 1,740.50 1,765.50 5,018,567
5th Oct 2026 (Mon) 1,786.50 1,789.50 1,755.00 1,759.00 3,779,090
2nd Oct 2026 (Fri) 1,781.00 1,802.00 1,770.00 1,779.50 5,629,788
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
28th Oct 2026 7:00 am RNS 3rd Quarter Results
26th Oct 2026 3:30 pm RNS Director/PDMR Shareholding
26th Oct 2026 3:30 pm RNS Ris-Rez positive Ph 3 osteosarcoma data in China
26th Oct 2026 7:05 am RNS Jemperli data show 76% complete response rate
26th Oct 2026 7:00 am RNS Positive Mo-Rez Phase Ib data in ovarian cancer
21st Oct 2026 7:00 am RNS US FDA approves Hibsago for chronic hepatitis B
19th Oct 2026 5:21 pm RNS Jemperli approved in MSI-H/dMMR rectal cancer
19th Oct 2026 7:00 am RNS Ris-Rez positive early data in lung cancer
15th Oct 2026 3:30 pm RNS Director/PDMR Shareholding
14th Oct 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

EXECUTIVE CHANGES: New board chairs for Adsure, EDX, Mpac and Pulsar

2nd Nov 2026 13:09

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: Berenberg cuts Haleon, Barclays cuts Dr Martens

2nd Nov 2026 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON BROKER RATINGS: Haleon hit with price target cuts by 7 brokers

30th Oct 2026 09:46

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BROKER RATINGS: Morgan Stanley raises Aviva; Jefferies cuts GSK

29th Oct 2026 10:06

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Monday: Read More

LONDON MARKET OPEN: FTSE 100 up as Shell surges; ECB, US data to come

29th Oct 2026 08:48

(Alliance News) - Stock prices in London opened higher on Thursday, with gains for oil major Shell helping the FTSE 100 advance, but earnings for banking firm Lloyds failed to inspire. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,768.51
Change38.73

Login to your account

Forgot Password?

Not Registered